Colin Walsh insider trades

Open-market stock purchases and sales by Colin Walsh, Director at Attovia Therapeutics, Inc, from SEC Form 4 filings since Aug 5, 2026.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +6%.

Recent trades

DateStockTradeValue
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 6, 2026ATTO Attovia Therapeutics, IncBought$8.5M
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 6, 2026ATTO Attovia Therapeutics, IncBought$8.5M
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 6, 2026ATTO Attovia Therapeutics, IncBought (not open market)—
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$1.6M
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$34.3K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$8.8K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$25.8K
Aug 5, 2026ATTO Attovia Therapeutics, IncBought$1.8M
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$21.8K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$9.8K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$29.3K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$74.9K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$22.9K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$6.3K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$9.6K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$15.4K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$25.8K
Aug 5, 2026ATTO Attovia Therapeutics, IncSold$146K

Companies traded

  • ATTO Attovia Therapeutics, Inc: 10 buys, 40 sales, last Aug 6, 2026

Get free alerts when Colin Walsh files a new trade →